Health Care · Electromedical & Electrotherapeutic Apparatus · Nasdaq · CIK 867840 · FYE Jun 30 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $4.44Day +4.23%Mkt cap $49M1Y −5.5%Off 52W high −27.8%Vol (1Y) 49.9%
Daily closing price, split-adjusted to the current basis; 3y shown of 922 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.2% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+9.98% |
| Top-10 13F concentration92.2% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$28.9M |
| Earnings (TTM)-$4.9M |
| ROE−51.8% |
| Net margin−30.3% |
| ROIC−36.3% |
| Debt / equity0.15× |
| Sales growth 3Y6.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+6.0% |
| 1Y−5.5% |
| 3Y−28.6% |
| Since incept. (ann.)−8.9% |
Total return through 2026-07-28 · series begins 2022-11-16. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)49.9% |
| Ann. volatility (3Y)49.8% |
| Sharpe (1Y)0.13 |
| Sharpe (3Y)0.04 |
| Max drawdown (1Y)−34.3% |
| Max drawdown (3Y)−45.4% |
| Beta (3Y vs SPY)0.97 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1.7M | $7M | 15.26% | +132.0% |
| MYDA Advisors LLC | 400,000 | $2M | 3.65% | new |
| Nantahala Capital Management, LLC | 280,000 | $1M | 2.56% | new |
| Bleichroeder LP | 270,925 | $1M | 2.48% | +23.0% |
| WealthTrust Axiom LLC | 254,108 | $1M | 2.32% | +9.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 194,125 | $852,209 | 1.77% | new |
| Archon Capital Management LLC | 156,805 | $688,374 | 1.43% | new |
| MORGAN STANLEY | 143,794 | $631,256 | 1.31% | +56.3% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | −$0.01 | — | $8.7M | +108.0% |
| 2025-12-31 | 2026-02-17 | −$0.23 | — | $7.4M | +62.8% |
| 2025-09-30 | 2025-11-13 | −$0.21 | — | $6.7M | +59.2% |
| 2025-06-30 | 2025-09-29 | — | — | $6.2M | +31.1% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Systems Manufacturing 43% · Engineering Design Services 26% · Ross Optical Industries 20% · Micro Optics Lab 11%
product & service · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
